CRISPR THERAPEUTICS AG (CRSP)

CH0334081137 - Common Stock

40.48  -0.24 (-0.59%)

After market: 40.56 +0.08 (+0.2%)

CRISPR THERAPEUTICS AG

NASDAQ:CRSP (12/23/2024, 4:30:00 PM)

After market: 40.56 +0.08 (+0.2%)

40.48

-0.24 (-0.59%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%28.37%
Sales Q2Q%N/A
CRS12.73
6 Month-25.05%
Overview
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-17 2025-02-17/amc
Ins Owners1.67%
Inst Owners71.32%
Market Cap3.45B
Shares85.35M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts73.71
Short Float %21.63%
Short Ratio11.2
IPO10-19 2016-10-19
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CRSP Daily chart

Company Profile

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company is headquartered in Zug, Zug and currently employs 407 full-time employees. The company went IPO on 2016-10-19. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The firm aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The firm has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The firm product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Company Info

CRISPR THERAPEUTICS AG

Baarerstrasse 14

Zug ZUG CH-6300

P: 41415613279

CEO: Samarth Kulkarni

Employees: 407

Website: https://crisprtx.com/

CRSP News

News Imagea day ago - The Motley FoolThis Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?
News Image3 days ago - Market News VideoInteresting CRSP Put And Call Options For February 2025
News Image3 days ago - The Motley Fool1 big new Green Flag for CRISPR Therapeutics' Stock
News Image3 days ago - Investor's Business DailyIs Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?

The company is still planning to move into Phase 3 testing, but analysts doubt the pain drug's future.

News Image6 days ago - The Motley Fool2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
News Image9 days ago - The Motley Fool3 Things You Need to Know if You Buy CRISPR Therapeutics Today

CRSP Twits

Here you can normally see the latest stock twits on CRSP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example